The global Oral Thin-film Drug Delivery Technology market size was valued at US$ 6868 million in 2024 and is forecast to a readjusted size of USD 9740 million by 2031 with a CAGR of 5.2% during review period.
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
This report is a detailed and comprehensive analysis for global Oral Thin-film Drug Delivery Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Thin-film Drug Delivery Technology market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oral Thin-film Drug Delivery Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oral Thin-film Drug Delivery Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oral Thin-film Drug Delivery Technology market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Thin-film Drug Delivery Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Thin-film Drug Delivery Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, LTS, J&J, Indivior, Pfizer, Church & Dwight, tesa Labtec, Tapemark, Prestige, MonoSol, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral Thin-film Drug Delivery Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
OTC
Rx
Market segment by Application
Hospitals
Drugstores
Others
Market segment by players, this report covers
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Thin-film Drug Delivery Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Thin-film Drug Delivery Technology, with revenue, gross margin, and global market share of Oral Thin-film Drug Delivery Technology from 2020 to 2025.
Chapter 3, the Oral Thin-film Drug Delivery Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Thin-film Drug Delivery Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Thin-film Drug Delivery Technology.
Chapter 13, to describe Oral Thin-film Drug Delivery Technology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oral Thin-film Drug Delivery Technology by Type
1.3.1 Overview: Global Oral Thin-film Drug Delivery Technology Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oral Thin-film Drug Delivery Technology Consumption Value Market Share by Type in 2024
1.3.3 OTC
1.3.4 Rx
1.4 Global Oral Thin-film Drug Delivery Technology Market by Application
1.4.1 Overview: Global Oral Thin-film Drug Delivery Technology Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Oral Thin-film Drug Delivery Technology Market Size & Forecast
1.6 Global Oral Thin-film Drug Delivery Technology Market Size and Forecast by Region
1.6.1 Global Oral Thin-film Drug Delivery Technology Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oral Thin-film Drug Delivery Technology Market Size by Region, (2020-2031)
1.6.3 North America Oral Thin-film Drug Delivery Technology Market Size and Prospect (2020-2031)
1.6.4 Europe Oral Thin-film Drug Delivery Technology Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oral Thin-film Drug Delivery Technology Market Size and Prospect (2020-2031)
1.6.6 South America Oral Thin-film Drug Delivery Technology Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oral Thin-film Drug Delivery Technology Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Oral Thin-film Drug Delivery Technology Product and Solutions
2.1.4 GSK Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GSK Recent Developments and Future Plans
2.2 LTS
2.2.1 LTS Details
2.2.2 LTS Major Business
2.2.3 LTS Oral Thin-film Drug Delivery Technology Product and Solutions
2.2.4 LTS Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 LTS Recent Developments and Future Plans
2.3 J&J
2.3.1 J&J Details
2.3.2 J&J Major Business
2.3.3 J&J Oral Thin-film Drug Delivery Technology Product and Solutions
2.3.4 J&J Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 J&J Recent Developments and Future Plans
2.4 Indivior
2.4.1 Indivior Details
2.4.2 Indivior Major Business
2.4.3 Indivior Oral Thin-film Drug Delivery Technology Product and Solutions
2.4.4 Indivior Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Indivior Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Oral Thin-film Drug Delivery Technology Product and Solutions
2.5.4 Pfizer Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Church & Dwight
2.6.1 Church & Dwight Details
2.6.2 Church & Dwight Major Business
2.6.3 Church & Dwight Oral Thin-film Drug Delivery Technology Product and Solutions
2.6.4 Church & Dwight Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Church & Dwight Recent Developments and Future Plans
2.7 tesa Labtec
2.7.1 tesa Labtec Details
2.7.2 tesa Labtec Major Business
2.7.3 tesa Labtec Oral Thin-film Drug Delivery Technology Product and Solutions
2.7.4 tesa Labtec Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 tesa Labtec Recent Developments and Future Plans
2.8 Tapemark
2.8.1 Tapemark Details
2.8.2 Tapemark Major Business
2.8.3 Tapemark Oral Thin-film Drug Delivery Technology Product and Solutions
2.8.4 Tapemark Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Tapemark Recent Developments and Future Plans
2.9 Prestige
2.9.1 Prestige Details
2.9.2 Prestige Major Business
2.9.3 Prestige Oral Thin-film Drug Delivery Technology Product and Solutions
2.9.4 Prestige Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Prestige Recent Developments and Future Plans
2.10 MonoSol
2.10.1 MonoSol Details
2.10.2 MonoSol Major Business
2.10.3 MonoSol Oral Thin-film Drug Delivery Technology Product and Solutions
2.10.4 MonoSol Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 MonoSol Recent Developments and Future Plans
2.11 BioDelivery
2.11.1 BioDelivery Details
2.11.2 BioDelivery Major Business
2.11.3 BioDelivery Oral Thin-film Drug Delivery Technology Product and Solutions
2.11.4 BioDelivery Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BioDelivery Recent Developments and Future Plans
2.12 Arx
2.12.1 Arx Details
2.12.2 Arx Major Business
2.12.3 Arx Oral Thin-film Drug Delivery Technology Product and Solutions
2.12.4 Arx Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Arx Recent Developments and Future Plans
2.13 ZIM
2.13.1 ZIM Details
2.13.2 ZIM Major Business
2.13.3 ZIM Oral Thin-film Drug Delivery Technology Product and Solutions
2.13.4 ZIM Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 ZIM Recent Developments and Future Plans
2.14 NAL Pharma
2.14.1 NAL Pharma Details
2.14.2 NAL Pharma Major Business
2.14.3 NAL Pharma Oral Thin-film Drug Delivery Technology Product and Solutions
2.14.4 NAL Pharma Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 NAL Pharma Recent Developments and Future Plans
2.15 AdhexPharma
2.15.1 AdhexPharma Details
2.15.2 AdhexPharma Major Business
2.15.3 AdhexPharma Oral Thin-film Drug Delivery Technology Product and Solutions
2.15.4 AdhexPharma Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 AdhexPharma Recent Developments and Future Plans
2.16 Aavishkar
2.16.1 Aavishkar Details
2.16.2 Aavishkar Major Business
2.16.3 Aavishkar Oral Thin-film Drug Delivery Technology Product and Solutions
2.16.4 Aavishkar Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Aavishkar Recent Developments and Future Plans
2.17 IntelGenx Corp
2.17.1 IntelGenx Corp Details
2.17.2 IntelGenx Corp Major Business
2.17.3 IntelGenx Corp Oral Thin-film Drug Delivery Technology Product and Solutions
2.17.4 IntelGenx Corp Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 IntelGenx Corp Recent Developments and Future Plans
2.18 APR
2.18.1 APR Details
2.18.2 APR Major Business
2.18.3 APR Oral Thin-film Drug Delivery Technology Product and Solutions
2.18.4 APR Oral Thin-film Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 APR Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Thin-film Drug Delivery Technology Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oral Thin-film Drug Delivery Technology by Company Revenue
3.2.2 Top 3 Oral Thin-film Drug Delivery Technology Players Market Share in 2024
3.2.3 Top 6 Oral Thin-film Drug Delivery Technology Players Market Share in 2024
3.3 Oral Thin-film Drug Delivery Technology Market: Overall Company Footprint Analysis
3.3.1 Oral Thin-film Drug Delivery Technology Market: Region Footprint
3.3.2 Oral Thin-film Drug Delivery Technology Market: Company Product Type Footprint
3.3.3 Oral Thin-film Drug Delivery Technology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oral Thin-film Drug Delivery Technology Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oral Thin-film Drug Delivery Technology Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Oral Thin-film Drug Delivery Technology Consumption Value Market Share by Application (2020-2025)
5.2 Global Oral Thin-film Drug Delivery Technology Market Forecast by Application (2026-2031)
6 North America
6.1 North America Oral Thin-film Drug Delivery Technology Consumption Value by Type (2020-2031)
6.2 North America Oral Thin-film Drug Delivery Technology Market Size by Application (2020-2031)
6.3 North America Oral Thin-film Drug Delivery Technology Market Size by Country
6.3.1 North America Oral Thin-film Drug Delivery Technology Consumption Value by Country (2020-2031)
6.3.2 United States Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
6.3.3 Canada Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
6.3.4 Mexico Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Oral Thin-film Drug Delivery Technology Consumption Value by Type (2020-2031)
7.2 Europe Oral Thin-film Drug Delivery Technology Consumption Value by Application (2020-2031)
7.3 Europe Oral Thin-film Drug Delivery Technology Market Size by Country
7.3.1 Europe Oral Thin-film Drug Delivery Technology Consumption Value by Country (2020-2031)
7.3.2 Germany Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
7.3.3 France Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
7.3.5 Russia Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
7.3.6 Italy Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Oral Thin-film Drug Delivery Technology Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oral Thin-film Drug Delivery Technology Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oral Thin-film Drug Delivery Technology Market Size by Region
8.3.1 Asia-Pacific Oral Thin-film Drug Delivery Technology Consumption Value by Region (2020-2031)
8.3.2 China Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8.3.3 Japan Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8.3.4 South Korea Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8.3.5 India Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
8.3.7 Australia Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
9 South America
9.1 South America Oral Thin-film Drug Delivery Technology Consumption Value by Type (2020-2031)
9.2 South America Oral Thin-film Drug Delivery Technology Consumption Value by Application (2020-2031)
9.3 South America Oral Thin-film Drug Delivery Technology Market Size by Country
9.3.1 South America Oral Thin-film Drug Delivery Technology Consumption Value by Country (2020-2031)
9.3.2 Brazil Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
9.3.3 Argentina Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Oral Thin-film Drug Delivery Technology Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oral Thin-film Drug Delivery Technology Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oral Thin-film Drug Delivery Technology Market Size by Country
10.3.1 Middle East & Africa Oral Thin-film Drug Delivery Technology Consumption Value by Country (2020-2031)
10.3.2 Turkey Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
10.3.4 UAE Oral Thin-film Drug Delivery Technology Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Oral Thin-film Drug Delivery Technology Market Drivers
11.2 Oral Thin-film Drug Delivery Technology Market Restraints
11.3 Oral Thin-film Drug Delivery Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Oral Thin-film Drug Delivery Technology Industry Chain
12.2 Oral Thin-film Drug Delivery Technology Upstream Analysis
12.3 Oral Thin-film Drug Delivery Technology Midstream Analysis
12.4 Oral Thin-film Drug Delivery Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
听
听
*If Applicable.
